Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?
Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…Clinical and polysomnographic features correlates to sleep-disordered breathing in multiple system atrophy
Objective: The purpose of this study is to elucidate whether sleep-discorded breathing (SDB) impact motor and non-motor symptoms in multiple system atrophy (MSA), and to…Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy
Objective: To find out hearing ability and speech discrimination of progressive supranuclear palsy (PSP) patients, we performed audiological evaluation by means of Pure Tone (PTA)…Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism
Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease
Objective: To evaluate the impact of comorbidities and compliance iniciatives on treatment efficacy in patients with Parkinson's disease. Methods: In the year 2014 we included…Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes
Objective: Swallow and speech disturbances are common in patients with atypical parkinsonism. The emergence of swallowing problems, or dysphagia, is associated with increased morbidity and…EBM review on the diagnostic work-up of multiple system atrophy
Objective: The International Parkinson and Movement Disorder Society (MDS)-endorsed MSA study group (MODIMSA) identified an urgent need to develop evidence-based recommendations for the diagnostic work-up…The importance of Ishihara testing in early diagnosing of Parkinson’s disease
Objective: Studying the importance of color differentiating in order to detect PD at earlier stages. Methods: Ishihara Test (IT) was experimented in 30 patients at…Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome
Objective: To elucidate specific clinical features of progressive supranuclear palsy (PSP) pathology in PSP syndrome. Background: PSP syndrome (PSPS) is the clinical hallmark of PSP;…Application and correlates of the PSP quality of life scale
Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.